Krka sells EUR 19.9 million of pharmaceuticals in Romania

Slovenian pharmaceutical producer Krka has obtained one of the highest sales increases in Romania in the first six months of the year, compared to other markets where the group operates. The company posted EUR 19.9 million, up 30 percent compared to the same period of last year. This came primarily from products for human consumption, including both products established for a number of years such as Bilobil (ginkgo biloba), among others. Romania is Krka's second largest market, after Croatia, in terms of sales volumes. The company witnessed a 34 percent increase in the sale of prescription pharmaceuticals in Romania during this interval. The increase in sales for self-medicated products was of 26 percent in Romania, which is among the top markets in this respect too. “Krka’s leading self-medication products are Bilobil, Pikovit, Herbion, Septolete and Duovit, to which the majority of advertising and other promotional activities are dedicated,” according to the company.